Interstage outcomes in single ventricle patients undergoing hybrid stage 1 palliation.
Janet M SimsicChristina PhelpsKristin KirchnerKirby-Rose CarpenitoRobin AllenHolly Miller-TateKaren TexterMark GalantowiczPublished in: Congenital heart disease (2018)
Interstage readmissions are common in the hybrid patient population. Seventeen percent were secondary to major adverse events. Interstage mortality was 7%. Future studies to identify interventions aimed at decreasing feeding issues and viral bronchiolitis in this tenuous patient population will hopefully improve quality outcomes, reduce readmissions, and lessen health care costs.
Keyphrases
- patients undergoing
- healthcare
- case report
- sars cov
- cardiovascular events
- mitral valve
- pulmonary artery
- heart failure
- current status
- coronary artery disease
- adipose tissue
- coronary artery
- respiratory syncytial virus
- pulmonary arterial hypertension
- case control
- congenital heart disease
- health insurance
- health information
- atrial fibrillation